Femasys (FEMY) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free FEMY Stock Alerts $1.27 -0.12 (-8.63%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAnalysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and Femasys (FEMY)markets.businessinsider.com - May 9 at 11:49 PMFEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q1 2024investorplace.com - May 9 at 2:11 PMFemasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Updateglobenewswire.com - May 9 at 8:30 AMFemasys Expands Commercial Management Team with Addition of Experienced New Hiresglobenewswire.com - May 7 at 8:30 AMCo-Diagnostics (NASDAQ:CODX) and Femasys (NASDAQ:FEMY) Financial Contrastamericanbankingnews.com - May 7 at 1:44 AMFemasys (NASDAQ:FEMY) Shares Up 4.5%americanbankingnews.com - May 4 at 3:16 AMFemasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiativesfinance.yahoo.com - April 18 at 8:41 AMFemasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women's Healthcare Initiativesglobenewswire.com - April 18 at 8:30 AMFemasys (FEMY) Price Target Increased by 5.41% to 9.95msn.com - April 17 at 6:04 PMFemasys Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - March 31 at 1:07 PMFEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q4 2023investorplace.com - March 28 at 11:31 PMFemasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Updateglobenewswire.com - March 28 at 4:05 PMAnalysts Are Bullish on Top Healthcare Stocks: Femasys (FEMY), BioNTech SE (BNTX)markets.businessinsider.com - March 21 at 7:05 PMFemasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscapeglobenewswire.com - March 21 at 9:00 AMFemasys Discloses Positive Data from FemaSeed Trialmarketwatch.com - March 21 at 3:11 AMFemasys Inc.: Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed for the Treatment of Infertilityfinanznachrichten.de - March 20 at 5:09 PMFemasys Announces Positive Data For FemaSeed Trial To Enhance Fertilization In Womenmarkets.businessinsider.com - March 20 at 5:09 PMFemasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertilityglobenewswire.com - March 20 at 8:15 AMFemasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024finance.yahoo.com - March 13 at 1:17 PMThinking about buying stock in Onespan, Avinger, Lithium Americas, Geron, or Femasys?morningstar.com - March 9 at 2:15 PMFemasys Inc.: Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solutionfinanznachrichten.de - March 6 at 7:08 PMFemasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solutionglobenewswire.com - March 6 at 9:00 AMFemasys Inc.: Femasys' FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVFfinanznachrichten.de - February 28 at 3:14 PMFemasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVFfinance.yahoo.com - February 28 at 10:14 AMFemasys' FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVFglobenewswire.com - February 28 at 9:00 AMFemasys Stock (NASDAQ:FEMY), Short Interest Reportbenzinga.com - February 24 at 8:03 PMT2 Biosystems, Invivyd among healthcare moversmsn.com - February 12 at 10:20 AMFemasys Welcomes New Chief Commercial Officer Mr. Spectormsn.com - February 7 at 5:40 PMFemasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecologyfinance.yahoo.com - January 23 at 12:00 PMFemasys Stock (NASDAQ:FEMY) Dividends: History, Yield and Datesbenzinga.com - December 27 at 1:58 PMFemasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicinefinance.yahoo.com - December 15 at 1:04 PMFemasys filed to sell 18.11M shares of common stock for holdersmsn.com - November 30 at 6:58 PMFemasys Names New Chief Medical Officerbaystreet.ca - November 30 at 1:57 PMFemasys appoints Liu as its chief medical officermsn.com - November 30 at 8:57 AMFemasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officerfinance.yahoo.com - November 30 at 8:57 AMFemasys: A Women's Health Medical Devices Company Ready To Turn The Cornerseekingalpha.com - November 28 at 1:23 PMFemasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launchfinance.yahoo.com - November 28 at 1:23 PMFemasys (FEMY): Solid Financials and Promising Product Developments Reinforce Buy Ratingmarkets.businessinsider.com - November 16 at 9:35 AMFemasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2023 and Provides Corporate Updatefinance.yahoo.com - November 14 at 9:26 AMFemasys Inc. EU MDR Final Audit Successfully Completedfinance.yahoo.com - October 26 at 12:51 PMFemasys Inc. to Showcase FemBloc and its other Novel Products Advancing Women’s Health at the American Association of Gynecologic Laparoscopic Surgeonsfinance.yahoo.com - October 25 at 10:17 AMFemasys (FEMY) to Report Q3 Earnings: What's in the Cards?finance.yahoo.com - October 24 at 8:01 AMFemasys Inc. Regains Compliance with Nasdaq Listing Requirementsfinance.yahoo.com - October 19 at 8:01 AMFemasys regains Nasdaq complianceseekingalpha.com - October 11 at 2:09 PMFemasys (FEMY) Price Target Increased by 72.09% to 9.44msn.com - October 5 at 9:57 AM5 of the Most Active Penny Stocks Worth Your Precious Time (FEMY)marketbeat.com - October 5 at 7:30 AMFemasys Inc. to Showcase FemaSeed at the Annual Meeting of the American Society of Reproductive Medicinefinance.yahoo.com - October 4 at 1:11 PMWhat's Going On With Femasys Stock Today?benzinga.com - October 3 at 4:05 PMFemasys Inc. MDSAP Surveillance Audit Successfully Completedfinance.yahoo.com - October 3 at 9:52 AMWhat's Going On With Femasys Stock?benzinga.com - October 2 at 2:09 PM Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Gold Set to EXPLODE! (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! FEMY Media Mentions By Week FEMY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FEMY News Sentiment▼-0.320.43▲Average Medical News Sentiment FEMY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FEMY Articles This Week▼71▲FEMY Articles Average Week Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NeuroOne Medical Technologies News Spectral AI News Akili News Retractable Technologies News Nephros News Inspira Technologies Oxy B.H.N. News PolyPid News Precision Optics News Modular Medical News LENSAR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FEMY) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersUrgent Nvidia WarningAltimetryObama’s Forever Term [exposed]Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Femasys Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
